S. Kelly Avants
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
S. Kelly Avants has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Arthur Margolin
7 shared publicationsLara A. Warburton
4 shared publicationsBruce J. Rounsaville
2 shared publications- Keith A. Hawkins
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
2 shared publications Thomas R. Kosten
2 shared publicationsAdeline Nyamathi
1 shared publication
Latest Publications
- 1 June 2001
- Published by Guilford Publications in AIDS Education and Prevention
- Vol. 13 (3) , 207-218
How Injection Drug Users Coped With Testing HIV-Seropositive: Implications for Subsequent Health-Related Behaviors
- 1 June 2001
- Published by Guilford Publications in AIDS Education and Prevention
- Vol. 13 (3) , 207-218
How Injection Drug Users Coped With Testing HIV-Seropositive: Implications for Subsequent Health-Related Behaviors
- 1 March 2001
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 33 (1) , 39-45
Spiritual and Religious Support in Recovery from Addiction Among HIV-Positive Injection Drug Users
The current study examined the association between support and comfort derived from religion or spirituality and abstinence from illicit drugs in a sample of 43 HIV-positive injection drug users entering a methadone maintenance program. Patients with high ratings of perceived spiritual or religious support were abstinent from illicit drugs significantly longer during the first six months of methadone maintenance than were patients with lower ratings. Controlling for the influence of pretreatment variables (addiction and psychiatric severity, CD4 count, social support, and optimism), and during-treatment variables (methadone dose and attendance at counseling sessions), hierarchical regression analysis showed that strength of religious and spiritual support was a significant independent predictor of abstinence. These findings suggest that spirituality may be an important dimension of patient experience to assess in future addiction treatment outcome research.
- 1 March 2001
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 33 (1) , 39-45
Spiritual and Religious Support in Recovery from Addiction Among HIV-Positive Injection Drug Users
The current study examined the association between support and comfort derived from religion or spirituality and abstinence from illicit drugs in a sample of 43 HIV-positive injection drug users entering a methadone maintenance program. Patients with high ratings of perceived spiritual or religious support were abstinent from illicit drugs significantly longer during the first six months of methadone maintenance than were patients with lower ratings. Controlling for the influence of pretreatment variables (addiction and psychiatric severity, CD4 count, social support, and optimism), and during-treatment variables (methadone dose and attendance at counseling sessions), hierarchical regression analysis showed that strength of religious and spiritual support was a significant independent predictor of abstinence. These findings suggest that spirituality may be an important dimension of patient experience to assess in future addiction treatment outcome research.
- 1 January 2001
- Published by Wiley in The American Journal on Addictions
- Vol. 10 (1) , 69-78
Predictors of Nonadherence to HIV‐Related Medication Regimens During Methadone Stabilization
Nonadherence to HIV‐related medication regimens among drug‐abusing patients decreases therapeutic effectiveness and may limit patient access to newer, highly active antiretroviral therapies (HAART). A number of factors have been associated with medication nonadherence; however, few studies have examined predictors of nonadherence specifically in HIV‐positive drug abusers. In the current study, a comprehensive assessment battery was administered to 42 HIV‐positive, injection drug users beginning methadone maintenance. HIV‐related medication adherence was assessed weekly by self‐report during the 4‐week methadone stabilization phase. Thirty‐six percent of patients reported less than 80% adherence to their medication regimen at entry into methadone. Medication adherence increased significantly during the 4‐week stabilization phase. Significant zero‐order correlations were found between nonadherence during stabilization and viral load, low educational attainment, depression, and neuropsychological tests of problem solving ability and cognitive flexibility. Independent predictors of nonadherence were low levels of education and poor emotional functioning. Implications for early intervention are discussed.
- 1 January 2001
- Published by Wiley in The American Journal on Addictions
- Vol. 10 (1) , 69-78
Predictors of Nonadherence to HIV‐Related Medication Regimens During Methadone Stabilization
Nonadherence to HIV‐related medication regimens among drug‐abusing patients decreases therapeutic effectiveness and may limit patient access to newer, highly active antiretroviral therapies (HAART). A number of factors have been associated with medication nonadherence; however, few studies have examined predictors of nonadherence specifically in HIV‐positive drug abusers. In the current study, a comprehensive assessment battery was administered to 42 HIV‐positive, injection drug users beginning methadone maintenance. HIV‐related medication adherence was assessed weekly by self‐report during the 4‐week methadone stabilization phase. Thirty‐six percent of patients reported less than 80% adherence to their medication regimen at entry into methadone. Medication adherence increased significantly during the 4‐week stabilization phase. Significant zero‐order correlations were found between nonadherence during stabilization and viral load, low educational attainment, depression, and neuropsychological tests of problem solving ability and cognitive flexibility. Independent predictors of nonadherence were low levels of education and poor emotional functioning. Implications for early intervention are discussed.
- 1 July 2000
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 19 (1) , 15-22
Continuation of high-risk behavior by HIV-positive drug users
- 1 July 2000
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 19 (1) , 15-22
Continuation of high-risk behavior by HIV-positive drug users
- 1 January 2000
- Published by Taylor & Francis in The American Journal of Drug and Alcohol Abuse
- Vol. 26 (3) , 399-416
The Influence of Coping and Depression on Abstinence from Illicit Drug Use in Methadone-Maintained Patients
Use of illicit drugs by opioid-dependent patients maintained on methadone undermines the benefits of methadone maintenance treatment. Because supplemental pharmacologic approaches have met with lim...
- 1 January 2000
- Published by Taylor & Francis in The American Journal of Drug and Alcohol Abuse
- Vol. 26 (3) , 399-416
The Influence of Coping and Depression on Abstinence from Illicit Drug Use in Methadone-Maintained Patients
Use of illicit drugs by opioid-dependent patients maintained on methadone undermines the benefits of methadone maintenance treatment. Because supplemental pharmacologic approaches have met with lim...
- 1 January 1999
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 156 (1) , 27-33
Day Treatment Versus Enhanced Standard Methadone Services for Opioid-Dependent Patients: A Comparison of Clinical Efficacy and Cost
This study examined the differential efficacy and relative costs of two intensities of adjunctive psychosocial services--a day treatment program and enhanced standard care--for the treatment of opioid-dependent patients maintained on methadone hydrochloride. A 12-week randomized clinical trial with 6-month follow-up was conducted in a community-based methadone maintenance program. Of the 308 patients who met inclusion criteria, 291 began treatment (day treatment program: N=145; enhanced standard care: N=146), and 237 completed treatment (82% of those assigned to the day treatment program and 81% of those receiving enhanced standard care). Two hundred twenty of the patients participated in the 6-month follow-up (75% of those in the day treatment program and 73% of those in enhanced standard care provided a follow-up urine sample for screening). Both interventions were 12 weeks in duration, manual-guided, and provided by master's-level clinicians. The day treatment was an intensive, 25-hour-per-week program. The enhanced standard care was standard methadone maintenance plus a weekly skills training group and referral to on- and off-site services. Outcome measures included twice weekly urine toxicology screens, severity of addiction-related problems, prevalence of HIV risk behaviors, and program costs. Although the cost of the day treatment program was significantly higher, there was no significant difference in the two groups' use of either opiates or cocaine. Over the course of treatment, drug use, drug-related problems, and HIV risk behaviors decreased significantly for patients assigned to both treatment intensities. Improvements were maintained at follow-up. Providing an intensive day treatment program to unemployed, inner-city methadone patients was not cost-effective relative to a program of enhanced methadone maintenance services, which produced comparable outcomes at less than half the cost.
- 1 January 1999
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 156 (1) , 27-33
Day Treatment Versus Enhanced Standard Methadone Services for Opioid-Dependent Patients: A Comparison of Clinical Efficacy and Cost
This study examined the differential efficacy and relative costs of two intensities of adjunctive psychosocial services--a day treatment program and enhanced standard care--for the treatment of opioid-dependent patients maintained on methadone hydrochloride. A 12-week randomized clinical trial with 6-month follow-up was conducted in a community-based methadone maintenance program. Of the 308 patients who met inclusion criteria, 291 began treatment (day treatment program: N=145; enhanced standard care: N=146), and 237 completed treatment (82% of those assigned to the day treatment program and 81% of those receiving enhanced standard care). Two hundred twenty of the patients participated in the 6-month follow-up (75% of those in the day treatment program and 73% of those in enhanced standard care provided a follow-up urine sample for screening). Both interventions were 12 weeks in duration, manual-guided, and provided by master's-level clinicians. The day treatment was an intensive, 25-hour-per-week program. The enhanced standard care was standard methadone maintenance plus a weekly skills training group and referral to on- and off-site services. Outcome measures included twice weekly urine toxicology screens, severity of addiction-related problems, prevalence of HIV risk behaviors, and program costs. Although the cost of the day treatment program was significantly higher, there was no significant difference in the two groups' use of either opiates or cocaine. Over the course of treatment, drug use, drug-related problems, and HIV risk behaviors decreased significantly for patients assigned to both treatment intensities. Improvements were maintained at follow-up. Providing an intensive day treatment program to unemployed, inner-city methadone patients was not cost-effective relative to a program of enhanced methadone maintenance services, which produced comparable outcomes at less than half the cost.
- 1 January 1998
- Published by American Psychological Association (APA) in Journal of Consulting and Clinical Psychology
- Vol. 66 (6) , 924-931
When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments.
In response to a need to match drug users to the most appropriate and cost-effective level of care, it was hypothesized the socially anxious methadone-maintained patients would attain greater benefit from coping skills training provided in the context of a low-intensity enhanced standard methadone maintenance intervention (E-STD) than in the context of a high-intensity, socially demanding day treatment program (DTP). Social anxiety was assessed in 307 methadone-maintained patients using the Social Anxiety and Distress Scale prior to randomization to either E-STD or DTP. The hypothesis was supported: Socially anxious patients were drug free longer during treatment, were more likely to be abstinent at treatment completion, and had greater reductions in HIV risk behaviors if assigned to the lower intensity intervention, which was provided at 1/3 the cost of the DTP.
- 1 January 1998
- Published by American Psychological Association (APA) in Journal of Consulting and Clinical Psychology
- Vol. 66 (6) , 924-931
When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments.
In response to a need to match drug users to the most appropriate and cost-effective level of care, it was hypothesized the socially anxious methadone-maintained patients would attain greater benefit from coping skills training provided in the context of a low-intensity enhanced standard methadone maintenance intervention (E-STD) than in the context of a high-intensity, socially demanding day treatment program (DTP). Social anxiety was assessed in 307 methadone-maintained patients using the Social Anxiety and Distress Scale prior to randomization to either E-STD or DTP. The hypothesis was supported: Socially anxious patients were drug free longer during treatment, were more likely to be abstinent at treatment completion, and had greater reductions in HIV risk behaviors if assigned to the lower intensity intervention, which was provided at 1/3 the cost of the DTP.